Biobetters (AAPS Advances in the Pharmaceutical Sciences Series) Book PDF, ePub eBook

Join our eBook service for unlimited books & audiobooks. Get a free 7 day subscription! ↓↓↓↓↓


Book Descriptions:
“Biobetters: Protein Engineering to Approach the Curative” discusses the optimization of protein therapeutic products for treatment of human diseases. It is based on the fact that though numerous important therapeutic protein products have been developed for life threatening and chronic diseases that possess acceptable safety and efficacy profiles, these products have generally not been reexamined and modified for an improved clinical performance, with enhancements both to safety and efficacy profiles. Advances in protein engineering, coupled with greatly enhanced understanding of critical product quality attributes for efficacy and safety, make it possible to optimize predecessor products for clinical performance, thereby enhancing patient quality of life and with the potential for great savings in health care costs. Yet despite such knowledge, there is little movement towards such modifications. This book examines engineering protein therapeutic products such that they exhibit an optimal, not just an adequate, clinical performance profile. Two product classes, therapeutic enzymes for lysosomal storage diseases (enzyme replacement therapies, ERT) and monoclonal antibodies (mAbs), are used as examples of what modifications to such proteins could be made to enhance clinical performance, “closer to a cure” as it were. For ERT, the key to optimizing clinical performance is to ensure the ERT is endowed with moieties that target the protein to the relevant target tissue. Thus, for Gaucher Disease, our best example of how to optimize an ERT to address a disease that manifests in specific target tissues (macrophages and monocytes), the enzyme has been extensively modified to target macrophages. For diseases such as Pompe Disease, largely a disorder of muscle, optimal performance of ERT will depend on endowing the enzyme with the ability to be taken up via the Mannose 6 Phosphate Receptor, and so one of the chapters in the book will discuss such approaches. Moreover, a major failure of biotechnology based products is to gain access to the CNS, a key target tissue in numerous diseases. Thus, a chapter has been devoted to strategies to access the CNS. Additionally, immune responses to therapeutic proteins can be highly problematic, eliminating the efficacy of life saving or highly effective protein therapeutics. This is especially poignant in the case of Pompe Disease wherein great improvement in muscle strength and functionality is lost following development of an immune response to the ERT with consequent patient deterioration and death. Thus, a chapter regarding protein engineering, as well as other non-clinical approaches to diminishing immunogenicity is a valuable part of the book. Monoclonal antibodies (mAbs) can be engineered to bind targets relevant to a wide variety of diseases; binding affinity, however, is only part of the equation and one of the chapters will present a molecular assessment approach that balances affinity with pharmacokinetics and manufacturability. As with other proteins immunogenicity can be problematic, being responsible for loss of efficacy of anti-TNF mAbs, often after prolonged successful treatment. The authors will also share their perspective on the consequences of physico-chemical modifications occurring to mAbs once they reach the circulation or their target, a research area open to further development from a protein engineering as well as analytical perspective. This book will also discuss novel platforms for protein therapeutics, technologies that exceed mAbs with respect to potency, and hence, potentially efficacy. These platforms consist largely of repeat domain proteins with very high affinity for their target ligands, but while potentially more efficacious, immunogenicity may be a major problem limiting use. The economics surrounding the issue of biobetters is another high-profile issue - this f

Biobetters (AAPS Advances in the Pharmaceutical Sciences Series) by Rosenberg, Demeule

From reader reviews:

Tara Huber:

Why don't make it to become your habit? Right now, try to prepare your time to do the important work, like looking for your favorite e-book and reading a guide. Beside you can solve your short lived problem; you can add your knowledge by the e-book entitled Biobetters (AAPS Advances in the Pharmaceutical Sciences Series). Try to the actual book Biobetters (AAPS Advances in the Pharmaceutical Sciences Series) as your pal. It means that it can to get your friend when you experience alone and beside associated with course make you smarter than in the past. Yeah, it is very fortuned for you personally. The book makes you considerably more confidence because you can know every little thing by the book. So , let us make new experience and knowledge with this book.

Tom Tucker:

The book Biobetters (AAPS Advances in the Pharmaceutical Sciences Series) make one feel enjoy for your spare time. You can use to make your capable more increase. Book can to get your best friend when you getting stress or having big problem along with your subject. If you can make studying a book Biobetters (AAPS Advances in the Pharmaceutical Sciences Series) being your habit, you can get considerably more advantages, like add your own capable, increase your knowledge about several or all subjects. You may know everything if you like start and read a book Biobetters (AAPS Advances in the Pharmaceutical Sciences Series). Kinds of book are several. It means that, science guide or encyclopedia or other individuals. So , how do you think about this publication?

Harrison Colon:

In this 21st centuries, people become competitive in every single way. By being competitive at this point, people have do something to make these individuals survives, being in the middle of the actual crowded place and notice by surrounding. One thing that often many people have underestimated it for a while is reading. Yeah, by reading a reserve your ability to survive increase then having chance to stand up than other is high. For you who want to start reading some sort of book, we give you that Biobetters (AAPS Advances in the Pharmaceutical Sciences Series) book as beginner and daily reading publication. Why, because this book is usually more than just a book.

Manuel Frazier:

The actual book Biobetters (AAPS Advances in the Pharmaceutical Sciences Series) has a lot associated with on it. So when you read this book you can get a lot of benefit. The book was published by the very famous author. The author makes some research before write this book. That book very easy to read you will get the point easily after reading this article book.